Mulligan M S, Vaporciyan A A, Warner R L, Jones M L, Foreman K E, Miyasaka M, Todd R F, Ward P A
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109.
J Immunol. 1995 Feb 1;154(3):1350-63.
By using the model of acute injury caused by intrapulmonary deposition of IgG immune complexes, blocking mAb to CD11a, CD11b, L-selectin, and intercellular adhesion molecule-1 (ICAM-1) were administered either i.v. or intratracheally (i.t.). The effects of these interventions were assessed according to lung injury, lung content of myeloperoxidase (MPO), TNF-alpha, and cellular content in bronchoalveolar lavage (BAL) fluids, and up-regulation of pulmonary vascular ICAM-1. In animals treated i.v. with Abs to CD11a, L-selectin, or ICAM-1 lung injury was significantly attenuated in parallel with reduced lung content of MPO. Under similar conditions, treatment with anti-CD11b had no effect. However, when the same mAb were administered i.t., anti-CD11a and anti-L-selectin were without protective effects, whereas i.t. administered anti-CD11b and anti-ICAM-1 were each highly protective. The protective effects of anti-CD11b were related to profound reductions in BAL levels of TNF-alpha, pulmonary vascular up-regulation of ICAM-1, and lung content of MPO. The protective effects of i.t.-administered anti-ICAM-1 were not associated with reduced BAL levels of TNF-alpha. Protective effects of mAb were also reflected in reductions of retrievable neutrophils in BAL fluids. mAb to rat CD11b and CD18 but not to rat CD11a suppressed in vitro production of TNF-alpha by immune complex-stimulated rat alveolar macrophages. The mAb did not reduce NO2-/NO3- generation in stimulated macrophages but all mAb (except anti-ICAM-1) reduced O2- responses in macrophages. These data suggest a compartmentalized role for adhesion molecules in lung inflammatory injury after intraalveolar deposition of IgG immune complexes, with CD11a, L-selectin, and ICAM-1 being important in the vascular compartment for neutrophil recruitment, whereas in the alveolar compartment CD11b and ICAM-1 (but not CD11a and L-selectin) seem to play key roles.
通过使用IgG免疫复合物肺内沉积所致急性损伤模型,静脉内(i.v.)或气管内(i.t.)给予抗CD11a、CD11b、L-选择素和细胞间黏附分子-1(ICAM-1)的阻断单克隆抗体(mAb)。根据肺损伤、肺髓过氧化物酶(MPO)含量、肿瘤坏死因子-α(TNF-α)以及支气管肺泡灌洗(BAL)液中的细胞成分,以及肺血管ICAM-1的上调情况来评估这些干预措施的效果。在静脉内给予抗CD11a、L-选择素或ICAM-1抗体的动物中,肺损伤明显减轻,同时肺内MPO含量降低。在类似条件下,抗CD11b治疗无效。然而,当相同的单克隆抗体经气管内给药时,抗CD11a和抗L-选择素没有保护作用,而气管内给予的抗CD11b和抗ICAM-1均具有高度保护作用。抗CD11b的保护作用与BAL液中TNF-α水平的显著降低、肺血管ICAM-1的上调以及肺内MPO含量有关。气管内给予抗ICAM-1的保护作用与BAL液中TNF-α水平的降低无关。单克隆抗体的保护作用还体现在BAL液中可回收中性粒细胞的减少上。抗大鼠CD11b和CD18而非抗大鼠CD11a的单克隆抗体抑制免疫复合物刺激的大鼠肺泡巨噬细胞体外TNF-α的产生。这些单克隆抗体不会降低刺激巨噬细胞中NO2-/NO3-的生成,但所有单克隆抗体(抗ICAM-1除外)都会降低巨噬细胞中的O2-反应。这些数据表明,黏附分子在IgG免疫复合物肺泡内沉积后肺部炎症损伤中具有分区作用,其中CD11a、L-选择素和ICAM-1在血管区对中性粒细胞募集很重要,而在肺泡区,CD11b和ICAM-1(而非CD11a和L-选择素)似乎起关键作用。